Novel Dementia Biomarkers
Investigating the Potential of Novel Dementia Biomarkers - an MRI, fNIRS and EEG Study
Sponsor: German Center for Neurodegenerative Diseases (DZNE)
This observational or N/A phase trial investigates Alzheimer Disease, Early Onset and is currently ongoing. German Center for Neurodegenerative Diseases (DZNE) leads this study, which shows 5 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jul 2022 — Jul 2024 [monthly]
Unknown Status
Status: Not Yet Recruiting → Unknown Status
-
Jan 2021 — Jul 2022 [monthly]
Not Yet Recruiting
-
Jul 2020 — Jan 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- German Center for Neurodegenerative Diseases (DZNE)
- Otto-von-Guericke University Magdeburg
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.